International Clinical Trial: Bacillus Probiotics With Bismuth Quadruple Therapy for Helicobacter Pylori Infection

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07827170) titled 'Bacillus Probiotics With Bismuth Quadruple Therapy for Helicobacter Pylori Infection' on Sept. 14.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Triple (Participant, Care Provider, Investigator).

Primary Sponsor: Anabio R&D

Condition: Helicobacter Pylori Infection Gastrointestinal Dysbiosis Antibiotic-associated Adverse Events

Intervention: Other: RO water Combination Product: LiveSpo CLAUSY

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: October 2026

Target Sample Size: 336

C...